LENSAR Inc (LNSR) - Cash Flow Conversion Efficiency
Based on the latest financial reports, LENSAR Inc (LNSR) has a cash flow conversion efficiency ratio of -0.009x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-127.00K) by net assets ($14.90 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see LENSAR Inc (LNSR) total market value for the company's overall valuation and market capitalisation.
LENSAR Inc - Cash Flow Conversion Efficiency Trend (2018–2025)
This chart illustrates how LENSAR Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data.
LENSAR Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of LENSAR Inc ranked by their cash flow conversion efficiency. Explore LENSAR Inc cash flow quality index to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Rimbunan Sawit Bhd
KLSE:5113
|
0.112x |
|
Banco Santander Río S.A
BA:BRIO
|
-0.322x |
|
Hasen-Immobilien AG
STU:ABHA
|
0.010x |
|
Coloray International Investment Co. Ltd
KQ:900310
|
0.003x |
|
MAISON POMMERY & ASSOCIES
PA:POMRY
|
-0.070x |
|
NIP Group Inc. American Depositary Shares
NASDAQ:NIPG
|
-0.004x |
|
GSD Holding AS
IS:GSDHO
|
0.028x |
|
Veracruz Properties SOCIMI SA
MC:YVCP
|
0.025x |
Annual Cash Flow Conversion Efficiency for LENSAR Inc (2018–2025)
The table below shows the annual cash flow conversion efficiency of LENSAR Inc from 2018 to 2025. View current stock price of LENSAR Inc for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $-26.02 Million | $-14.83 Million | 0.570x | +567.18% |
| 2024-12-31 | $18.65 Million | $-2.27 Million | -0.122x | +40.41% |
| 2023-12-31 | $47.18 Million | $-9.66 Million | -0.205x | +42.14% |
| 2022-12-31 | $41.98 Million | $-14.86 Million | -0.354x | -116.51% |
| 2021-12-31 | $54.88 Million | $-8.97 Million | -0.163x | +20.35% |
| 2020-12-31 | $67.21 Million | $-13.79 Million | -0.205x | -149.80% |
| 2019-12-31 | $-30.55 Million | $-12.59 Million | 0.412x | +347.34% |
| 2018-12-31 | $-20.46 Million | $-1.89 Million | 0.092x | -- |
About LENSAR Inc
LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing laser systems for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism in the United System, Europe, Asia, South Korea, and internationally. The company offers the LENSAR Laser System, which incorporates a range of proprietary technologies des… Read more